Same-day correction of baselines for demand response using long short-term memory

In incentive-based the Demand Response, the amount of electricity demand reduction is calculated by subtracting actual electricity demand from the baseline (BL). The BL is the estimated electricity demand of households when no electricity demand suppression is performed. In Japan, the high 4 of 5 method is used to forecast the BL by averaging the actual demand of the day. In this study, we refer to the high 4 of 5 method as BL1. BL2 is the BL to which the value of the same-day adjustment is added based on the actual demand of the day. BL3 is BL1 plus the value of the same-day adjustment predicted using Long Short-Term Memory (LSTM). The average MAE values for BL2 and BL3, calculated using actual electricity demand data from October 15, 2021, to December 24, 2021, were 11.2 kW and 8.1 kW, respectively, with BL3 being 3.1 kW smaller than BL2. To estimate the confidence intervals for BL2 and BL3, we calculated the error by subtracting each BL from the actual value and calculated the ±3σ equivalent for the distribution of the error. The confidence interval calculated for BL3 was found to be ±9.2 kW lower than that for BL2. The F-test for the distribution of the errors for BL2 and BL3 yielded a P-value of 4.05 × 10-50, indicating that the variances of the two distributions were not equally distributed

Regulation of energy metabolism by interleukin-1 β, but not by interleukin-6, is mediated by nitric oxide in primary cultured rat hepatocytes

AbstractThe effects of inflammatory cytokines (interleukin-1 β, interleukin-6, and tumor necrosis factor-α) on energy metabolism were studied in primary cultured rat hepatocytes. Adenine nucleotide (ATP, ADP, and AMP) content, lactate production, the ketone body ratio (acetoacetate/β-hydroxybutyrate) reflecting the liver mitochondrial redox state (NAD+/NADH), and nitric oxide formation were measured. Insulin increased ATP content in hepatocytes and had a maximal effect after 8–12 h of culture. Both interleukin-1β and interleukin-6, but not tumor necrosis factor-α, significantly inhibited the ATP increase time- and dose-dependently. Interleukin-1β and interleukin-6 also stimulated lactate production. During the same period, interleukin-1 β but not interleukin-6 decreased the ketone body ratio. Furthermore, interleukin-1 β markedly stimulated nitric oxide formation in hepatocytes, and this increase was blocked by NG-monomethyl-L-arginine (a nitric oxide synthase inhibitor) and by interleukin-1 receptor antagonist. NG-monomethyl-l-arginine reversed inhibition of the ATP increase, decrease in the ketone body ratio, and increase in lactate production, which were induced by interleukin-lβ. Interleukin-1 receptor antagonist completely abolished all of the effects induced by interleukin-1 β. These results demonstrated that interleukin-1 β and interleukin-6 affect the insulin-induced energy metabolism in rat hepatocytes by different mechanisms. Specifically, interleukin-1 β inhibits ATP synthesis by causing the mitochondrial dysfunction, a process which may be mediated by nitric oxide

Large enhancement of superconducting transition temperature in single-element superconducting rhenium by shear strain

Finding a physical approach for increasing the superconducting transition temperature (Tc) is a challenge in the field of material science. Shear strain effects on the superconductivity of rhenium were investigated using magnetic measurements, X-ray diffraction, transmission electron microscopy, and first-principles calculations. A large shear strain reduces the grain size and simultaneously expands the unit cells, resulting in an increase in Tc. Here we show that this shear strain approach is a new method for enhancing Tc and differs from that using hydrostatic strain. The enhancement of Tc is explained by an increase in net electron–electron coupling rather than a change in the density of states near the Fermi level. The shear strain effect in rhenium could be a successful example of manipulating Bardeen–Cooper–Schrieffer-type Cooper pairing, in which the unit cell volumes are indeed a key parameter

Radiofrequency Ablation of Lung Cancer at Okayama University Hospital: A Review of 10 Years of Experience

The application of radiofrequency ablation for the treatment of lung cancer by our group at Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences began in June 2001, and in the present report, we review our 10-year experience with this treatment modality at Okayama University Hospital. The local efficacy of radiofrequency ablation for the treatment of lung cancer depends on tumor size and the type of electrode used, but not on tumor type. An important factor for the prevention of local failure may be the acquisition of an adequate ablative margin. The combination of embolization and radiation therapy enhances the local efficacy. Local failure may be salvaged by repeating the radiofrequency ablation, particularly in small tumors. Survival rates after radiofrequency ablation are quite promising for patients with clinical stage I non-small cell lung cancer and pulmonary metastasis from colorectal cancer, hepatocellular carcinoma, and renal cell carcinoma. The complications caused by radiofrequency ablation can be treated conservatively in the majority of cases. However, attention should be paid to rare but serious complications. This review shows that radiofrequency ablation is a promising treatment for patients with lung cancer

Factors related to renal cortical atrophy development after glucocorticoid therapy in IgG4-related kidney disease: a retrospective multicenter study.

Background: In immunoglobulin G4-related kidney disease (IgG4-RKD), focal or diffuse renal cortical atrophy is often observed in the clinical course after glucocorticoid therapy. This study aimed to clarify the factors related to renal atrophy after glucocorticoid therapy in IgG4-RKD. Methods: We retrospectively evaluated clinical features including laboratory data and computed tomography (CT) findings before and after glucocorticoid therapy in 23 patients diagnosed with IgG4-RKD, all of whom were followed up for more than 24 months. Results: Seventeen patients were men, and six were women (average age 62.0 years). Average follow-up period was 54.9 months. The average estimated glomerular filtration rate (eGFR) at diagnosis was 81.7 mL/min/1.73 m2. All patients had had multiple low-density lesions on contrast-enhanced CT before glucocorticoid therapy, and showed disappearance or reduction of these lesions after it. Pre-treatment eGFR and serum IgE level in 11 patients in whom renal cortical atrophy developed 24 months after the start of glucocorticoid therapy were significantly different from those in 12 patients in whom no obvious atrophy was found at that time (68.9 ± 30.1 vs 93.5 ± 14.1 mL/min/1.73 m2, P = 0.036, and 587 ± 254 vs 284 ± 263 IU/mL, P = 0.008, respectively). Pre-treatment eGFR and serum IgE level were also significant risk factors for renal atrophy development 24 months after the start of therapy with an odds ratio of 0.520 (per 10 mL/min/1.73 m2, 95% confidence interval (CI) 0.273-0.993, P = 0.048) and 1.090 (per 10 IU/mL, 95% CI: 1.013-1.174, P = 0.022), respectively, in age-adjusted, sex-adjusted, serum IgG4 level-adjusted logistic regression analysis. Receiver operating characteristic curve analysis showed that eGFR of less than 71.0 mL/min/1.73 m2 and serum IgE of more than 436.5 IU/mL were the most appropriate cutoffs and yielded sensitivity of 63.6% and specificity of 100%, and sensitivity of 90.9% and specificity of 75.0%, respectively, in predicting renal atrophy development. Conclusions: This study suggests that pre-treatment renal insufficiency and serum IgE elevation predict renal atrophy development after glucocorticoid therapy in IgG4-RKD. © 2016 The Author(s)

Clinical course after corticosteroid therapy in IgG4-related aortitis/periaortitis and periarteritis: A retrospective multicenter study

金沢大学医薬保健研究域医学系Introduction: Immunoglobulin G4 (IgG4)-related aortitis/periaortitis and periarteritis are vascular manifestations of IgG4-related disease. In this disease, the affected aneurysmal lesion has been suspected to be at risk of rupture. In this study, we aimed to clarify the clinical course after corticosteroid therapy in IgG4-related aortitis/periaortitis and periarteritis.Methods: We retrospectively evaluated clinical features, including laboratory data, imaging findings and the course after corticosteroid therapy, in 40 patients diagnosed with IgG4-related aortitis/periaortitis and periarteritis on the basis of periaortic/periarterial radiological findings, satisfaction of the comprehensive diagnostic criteria or each organ-specific diagnostic criteria, and exclusion of other diseases. Results: The patients were mainly elderly, with an average age of 66.4 years and with a marked male predominance and extensive other organ involvement. Subjective symptoms were scanty, and only a small proportion had elevated serum C-reactive protein levels. The affected aorta/artery were the abdominal aortas or the iliac arteries in most cases. Thirty-six patients were treated with prednisolone, and the periaortic/periarterial lesions improved in most of them during the follow-up period. Two (50.0%) of four patients with luminal dilatation of the affected lesions before corticosteroid therapy had exacerbations of luminal dilatation after therapy, whereas none of the twenty-six patients without it had a new appearance of luminal dilatation after therapy. Conclusions: The results of this retrospective multicenter study highlight three important points: (1) the possibility of latent existence and progression of periaortic/periarterial lesions, (2) the efficacy of corticosteroid therapy in preventing new aneurysm formation in patients without luminal dilatation of periaortic/periarterial lesions and (3) the possibility that a small proportion of patients may actually develop luminal dilatation of periaortic/periarterial lesions in IgG4-related aortitis/periaortitis and periarteritis. A larger-scale prospective study is required to confirm the efficacy and safety of corticosteroid therapy in patients with versus those without luminal dilatation and to devise a more useful and safe treatment strategy, including administration of other immunosuppressants. © 2014 Mizushima et al.; licensee BioMed Central Ltd

The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force

「コロナ制圧タスクフォース」COVID-19患者由来の血液細胞における遺伝子発現の網羅的解析 --重症度に応じた遺伝子発現の変化には、ヒトゲノム配列の個人差が影響する--. 京都大学プレスリリース. 2022-08-23.Coronavirus disease 2019 (COVID-19) is a recently-emerged infectious disease that has caused millions of deaths, where comprehensive understanding of disease mechanisms is still unestablished. In particular, studies of gene expression dynamics and regulation landscape in COVID-19 infected individuals are limited. Here, we report on a thorough analysis of whole blood RNA-seq data from 465 genotyped samples from the Japan COVID-19 Task Force, including 359 severe and 106 non-severe COVID-19 cases. We discover 1169 putative causal expression quantitative trait loci (eQTLs) including 34 possible colocalizations with biobank fine-mapping results of hematopoietic traits in a Japanese population, 1549 putative causal splice QTLs (sQTLs; e.g. two independent sQTLs at TOR1AIP1), as well as biologically interpretable trans-eQTL examples (e.g., REST and STING1), all fine-mapped at single variant resolution. We perform differential gene expression analysis to elucidate 198 genes with increased expression in severe COVID-19 cases and enriched for innate immune-related functions. Finally, we evaluate the limited but non-zero effect of COVID-19 phenotype on eQTL discovery, and highlight the presence of COVID-19 severity-interaction eQTLs (ieQTLs; e.g., CLEC4C and MYBL2). Our study provides a comprehensive catalog of whole blood regulatory variants in Japanese, as well as a reference for transcriptional landscapes in response to COVID-19 infection

DOCK2 is involved in the host genetics and biology of severe COVID-19

「コロナ制圧タスクフォース」COVID-19疾患感受性遺伝子DOCK2の重症化機序を解明 --アジア最大のバイオレポジトリーでCOVID-19の治療標的を発見--. 京都大学プレスリリース. 2022-08-10.Identifying the host genetic factors underlying severe COVID-19 is an emerging challenge. Here we conducted a genome-wide association study (GWAS) involving 2, 393 cases of COVID-19 in a cohort of Japanese individuals collected during the initial waves of the pandemic, with 3, 289 unaffected controls. We identified a variant on chromosome 5 at 5q35 (rs60200309-A), close to the dedicator of cytokinesis 2 gene (DOCK2), which was associated with severe COVID-19 in patients less than 65 years of age. This risk allele was prevalent in East Asian individuals but rare in Europeans, highlighting the value of genome-wide association studies in non-European populations. RNA-sequencing analysis of 473 bulk peripheral blood samples identified decreased expression of DOCK2 associated with the risk allele in these younger patients. DOCK2 expression was suppressed in patients with severe cases of COVID-19. Single-cell RNA-sequencing analysis (n = 61 individuals) identified cell-type-specific downregulation of DOCK2 and a COVID-19-specific decreasing effect of the risk allele on DOCK2 expression in non-classical monocytes. Immunohistochemistry of lung specimens from patients with severe COVID-19 pneumonia showed suppressed DOCK2 expression. Moreover, inhibition of DOCK2 function with CPYPP increased the severity of pneumonia in a Syrian hamster model of SARS-CoV-2 infection, characterized by weight loss, lung oedema, enhanced viral loads, impaired macrophage recruitment and dysregulated type I interferon responses. We conclude that DOCK2 has an important role in the host immune response to SARS-CoV-2 infection and the development of severe COVID-19, and could be further explored as a potential biomarker and/or therapeutic target

Sulfate ion in raw water affects performance of high-basicity PACl coagulants produced by Al(OH)₃ dissolution and base-titration : removal of SPAC particles by coagulation-flocculation, sedimentation, and sand filtration

Many PACl (poly-aluminum chloride) coagulants with different characteristics have been trial-produced in laboratories and commercially produced, but the selection of a proper PACl still requires empirical information and field testing. Even PACls with the same property sometimes show different coagulation performances. In this study, we compared PACls produced by AlCl₃-titration and Al(OH)₃-dissolution on their performance during coagulation-flocculation, sedimentation, and sand filtration (CSF) processes. The removal targets were particles of superfine powdered activated carbon (SPAC), which are used for efficient adsorptive removal of micropollutants, but strict removal of SPAC is required because of the high risk of their leakage after CSF. PACls of high-basicity produced by AlCl3-titration and Al(OH)3-dissolution were the same in terms of the ferron assay and colloid charge, but their performance in CSF were completely different. High-basicity Al(OH)₃-dissolution PACls formed large floc particles and yielded very few remaining SPAC particles in the filtrate, whereas high-basicity AlCl₃-titration PACls did not form large floc particles. High-basicity PACls produced by Al(OH)₃-dissolution were superior to low-basicity PACl in lowering remaining SPAC particles by the same method because of their high charge neutralization capacity, although their floc formation ability was similar or slightly inferior. However, high-basicity Al(OH)₃-dissolution PACl was inferior when the sulfate ion concentration in the raw water was low. Sulfate ions were required in the raw water for high-basicity PACls to be effective in floc formation. In particular, very high sulfate concentrations were required for high-basicity AlCl₃-titration PACls. The rate of hydrolysis, which is related to the polymerization of aluminum species, is a key property, besides charge neutralization capacity, for proper coagulation, including formation of large floc particles. The aluminum species in the high-basicity PACls, in particular that produced by AlCl₃-titration, was resistant to hydrolysis, but sulfate ions in raw water accelerated the rate of hydrolysis and thereby facilitated floc formation. Normal-basicity Al(OH)₃-dissolution PACl was hydrolysis-prone, even without sulfate ions. Aluminum species in the high-basicity AlCl₃-titration PACl were mostly those with a molecular weight (MW) of 1–10 kDa, whereas those of high-basicity Al(OH)₃-dissolution PACls were mostly characterized by a MW >10 kDa. Normal-basicity Al(OH)₃-dissolution PACl was the least polymerized and contained monomeric species

Stray particles as the source of residuals in sand filtrate : Behavior of superfine powdered activated carbon particles in water treatment processes

Although superfine powdered activated carbon has excellent adsorption properties, it is not used in conventional water treatment processes comprising coagulation–flocculation, sedimentation, and sand filtration (CSF) due to concerns about its residual in treated water. Here, we examined the production and fate of very fine carbon particles with lacking in charge neutralization as a source of the residual in sand filtrate after CSF treatment. Almost all of the carbon particles in the water were charge-neutralized by coagulation treatment with rapid mixing, but a very small amount (≤0.4% of the initial concentration) of very fine carbon particles with a lesser degree of charge neutralization were left behind in coagulation process. Such carbon particles, defined as stray carbon particles, were hardly removed by subsequent flocculation and sedimentation processes, and some of them remained in the sand filtrate. The concentration of residual carbon particles in the sand filtrate varied similarly with that of the stray carbon particles. The stray and residual carbon particles were similarly smaller than the particles before coagulation treatment, but the residual carbon particles had less charge neutralization than the stray carbon particles. The turbidity of water samples collected after sedimentation was not correlated with the residual carbon concentration in the sand filtrate, even though it is often used as an indicator of treatment performance with respect to the removal of suspended matter. Based on these findings, we suggest that reduction of the amount of stray particles should be a performance goal of the CSF treatment. Examining this concept further, we confirmed that the residence time distributions in the coagulation and flocculation reactors influenced the concentration of stray carbon particles and then the residual carbon particle concentration in sand filtrate, but found that the effect was dependent on coagulant type. A multi-chambered-reactor configuration lowered both the stray carbon particle concentration after coagulation treatment and the residual carbon particle concentration in sand filtrate compared with a single-chambered reactor configuration. When a normal basicity PACl that consisted mainly of monomeric Al species was used, the stray carbon particle concentration was decreased during coagulation process and then gradually decreased during subsequent flocculation process because the monomeric Al species were transformed to colloidal Al species via polymeric Al species. In contrast, when a high-basicity PACl that consisted mostly of colloidal Al species was used, coagulation treatment largely decreased the stray carbon particle concentration, which did not decrease further during subsequent flocculation process. These findings will be valuable for controlling residual carbon particles after the CSF treatment